These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24906060)

  • 1. An Evaluation of Statistical Methods for Analyzing Follow-Up Gaussian Laboratory Data with a Lower Quantification Limit.
    Karon JM; Wiegand RE; van de Wijgert JH; Kilmarx PH
    J Biopharm Stat; 2015; 25(4):812-29. PubMed ID: 24906060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors.
    Soret P; Avalos M; Wittkop L; Commenges D; Thiébaut R
    BMC Med Res Methodol; 2018 Dec; 18(1):159. PubMed ID: 30514234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating and comparing reduction in HIV-1 RNA in clinical trials using methods for interval censored data.
    Flandre P; Alcais A; Descamps D; Morand-Joubert L; Joly V
    J Acquir Immune Defic Syndr; 2004 Mar; 35(3):286-92. PubMed ID: 15076244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of methods for analyzing left-censored occupational exposure data.
    Huynh T; Ramachandran G; Banerjee S; Monteiro J; Stenzel M; Sandler DP; Engel LS; Kwok RK; Blair A; Stewart PA
    Ann Occup Hyg; 2014 Nov; 58(9):1126-42. PubMed ID: 25261453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of models for analyzing two-group, cross-sectional data with a Gaussian outcome subject to a detection limit.
    Wiegand RE; Rose CE; Karon JM
    Stat Methods Med Res; 2016 Dec; 25(6):2733-2749. PubMed ID: 24803511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear and nonlinear mixed-effects models for censored HIV viral loads using normal/independent distributions.
    Lachos VH; Bandyopadhyay D; Dey DK
    Biometrics; 2011 Dec; 67(4):1594-604. PubMed ID: 21504417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of left-censored longitudinal data with application to viral load in HIV infection.
    Jacqmin-Gadda H; Thiébaut R; Chêne G; Commenges D
    Biostatistics; 2000 Dec; 1(4):355-68. PubMed ID: 12933561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observations below multiple lower limits of quantification: How to estimate the mean and variance.
    Berger T; Hilgers RD; Heussen N
    Biom J; 2019 Sep; 61(5):1258-1269. PubMed ID: 30221408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical Bayes Gaussian likelihood estimation of exposure distributions from pooled samples in human biomonitoring.
    Li X; Kuk AY; Xu J
    Stat Med; 2014 Dec; 33(28):4999-5014. PubMed ID: 25213192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximum likelihood inference for left-censored HIV RNA data.
    Lynn HS
    Stat Med; 2001 Jan; 20(1):33-45. PubMed ID: 11135346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fundamentals of Research Data and Variables: The Devil Is in the Details.
    Vetter TR
    Anesth Analg; 2017 Oct; 125(4):1375-1380. PubMed ID: 28787341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Method for Imputing Censored Values in Crossover Designs with Time-to-Event Outcomes Using Median Residual Life.
    Jalali M; Bagheri Z; Zare N; Ayatollahi SMT
    Biomed Res Int; 2020; 2020():8475154. PubMed ID: 33376742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixture models for calibrating the BED for HIV incidence testing.
    Mahiane SG; Fiamma A; Auvert B
    Stat Med; 2014 May; 33(10):1767-83. PubMed ID: 24834521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of toxicokinetic data using NONMEM: impact of quantification limit and replacement strategies for censored data.
    Hing JP; Woolfrey SG; Greenslade D; Wright PM
    J Pharmacokinet Pharmacodyn; 2001 Oct; 28(5):465-79. PubMed ID: 11768291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of censoring data below an arbitrary quantification limit on structural model misspecification.
    Byon W; Fletcher CV; Brundage RC
    J Pharmacokinet Pharmacodyn; 2008 Feb; 35(1):101-16. PubMed ID: 17963024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference interval estimation: Methodological comparison using extensive simulations and empirical data.
    Daly CH; Higgins V; Adeli K; Grey VL; Hamid JS
    Clin Biochem; 2017 Dec; 50(18):1145-1158. PubMed ID: 28733190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of interval censoring in parametric regression models.
    Lindsey JK
    Lifetime Data Anal; 1998; 4(4):329-54. PubMed ID: 9880994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation and inference on correlations between biomarkers with repeated measures and left-censoring due to minimum detection levels.
    Xie X; Xue X; Gange SJ; Strickler HD; Kim MY;
    Stat Med; 2012 Sep; 31(21):2275-89. PubMed ID: 22714546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.